2009 Annual Meeting | Criteria for Stopping and Starting Multiple Sclerosis Therapy

�鶹��ýӳ��

2009 Annual Meeting | Criteria for Stopping and Starting Multiple Sclerosis Therapy

Date Monday 04/27/09

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Gary Birnbaum, MD, F�鶹��ýӳ��

Topic(s)

Learning Objectives Participants should be familiar with some of the variables and difficulties involved in deciding when to start treatment with disease-modifying therapies in RRMS and when to stop such treatments in persons possibly no longer benefiting from them.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
06:45 AM - 07:15 AM		When to Start Disease-Modifying Therapy in MS Gary Birnbaum, MD, F�鶹��ýӳ��
06:45 AM - 08:30 AM		Breakfast
07:15 AM - 07:45 AM		When to Stop Disease-Modifying Therapy in MS Aaron E. Miller, MD, F�鶹��ýӳ��
07:45 AM - 08:00 AM		Break
08:00 AM - 08:30 AM		Questions and Answers

Faculty Disclosures
Gary Birnbaum, MD, F�鶹��ýӳ��	No disclosure on file
Aaron E. Miller, MD, F�鶹��ýӳ��	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.